secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Health, Inc. (ODYY)
CIK:        0001626644
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001683168-22-008027
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Health acquires option to purchase PRV-001 patents from Prevacus for 1M shares
--------------------------------------------------------------------------------

- Option to buy 100% of worldwide patents to PRV-001 and an Enantiomer from Prevacus.
- Consideration for option: 1,000,000 shares of Odyssey common stock.
- If exercised, asset purchase price: 2M shares for PRV-001, 1M shares for Enantiomer.
- Option exercisable within 180 days of Nov 22, 2022; closing within 90 days after exercise.
- Odyssey will also enter an asset purchase agreement upon exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626644/000168316822008027/0001683168-22-008027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626644/000168316822008027/odyssey_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer